Toshiba was unable to complete the sale to a consortium led by U.S. private equity firm Bain Capital by the agreed deadline as it was still waiting for approval from China’s anti-monopoly regulator. Toshiba will not use the option of canceling the $18 billion sale of its memory chip unit unless there is any “major material change” in circumstances.